Purchase Order HHSN275201600781P
Award Date 9/8/16
Potential Completion Date 9/16/16
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institutes of Health's National Institute of Child Health and Human Development awarded a $13,936.77 firm fixed price purchase order to Genscript USA Inc. for gene synthesis services. The place of performance is Bethesda, Maryland. The one-year contract runs from August 17, 2023 through August 16, 2024 to support NICHD's research programs. As a leading biotechnology company, Genscript will leverage its expertise in gene engineering to deliver customized genetic material and...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a $10,000 purchase order to Genscript USA Inc. to deliver a 2000 base pair gene synthesis in a PUC57 vector with 4 micrograms of the synthesized gene. The place of performance for this firm fixed price contract is in Bethesda, Maryland. This purchase supports the NIH's mission to conduct and fund medical research that could improve public health, likely...
- This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), which is part of the Department of Health and Human Services (HHS). The contract was awarded to Genscript USA Inc., a small business biotechnology company based in Piscataway, New Jersey, for $11,434.95. The contract has an ultimate completion date of July 30, 2025. Genscript specializes in gene synthesis, gene editing, custom protein and antibody production, and other...
- This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health (NIH), to GenScript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $65,963.22 contract is for gene synthesis and related services to support NICHD's research on how transcription factors regulate gene expression and chromatin structure. The award stems from a sole-source special notice solicitation, as NICHD...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a $4,580 purchase order contract to Genscript USA Inc. to provide customized protein services. The contract has a firm fixed price and will be performed in Bethesda, Maryland over a five-month period concluding in April 2017. No set-aside designation or subcontractors were indicated. The National Institute of Child Health and Human Development conducts...
- This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $10,982.04 contract is for the provision of customized protein services, gene synthesis, and other molecular biology products and services to support biomedical research and public health initiatives. The contract does not...
- This is a $14,500 firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey. The contract is for NICHD laboratory services and does not have a set-aside designation. Genscript is a provider of a wide range of molecular biology products and services to federal agencies, including gene...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $20,000 firm fixed price purchase order to Genscript USA Inc. to provide custom gene synthesis services. The contract will support NIH's research efforts at its Bethesda, Maryland campus through December 31, 2023. Genscript will deliver custom gene synthesis products to NIH researchers as part of the Institute's work to advance understanding of diseases...
- This federal contract award was made by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $4,385.32 firm fixed-price purchase order is for gene synthesis services to support NICHD's research activities. The contract does not have a set-aside designation. Genscript USA Inc. is a for-profit organization that has...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a $6,492.65 firm fixed price purchase order to Genscript USA Inc. of Piscataway, New Jersey. Under the contract, Genscript will provide anti-acetylated K421 to the NIH/NICHD between May 11, 2018 and August 31, 2018 to support the agency's biomedical research efforts. No additional details were provided regarding the original solicitation, use of...